BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32584170)

  • 1. Identification of the Novel Target Genes for Osteosarcoma Therapy Based on Comprehensive Bioinformatic Analysis.
    Zhou X; Fan Y; Ye W; Jia B; Yang Y; Liu Y
    DNA Cell Biol; 2020 Jul; 39(7):1172-1180. PubMed ID: 32584170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of miRNA-542-5p in the tumorigenesis of osteosarcoma.
    Zhu T; Fan D; Ye K; Liu B; Cui Z; Liu Z; Tian Y
    FEBS Open Bio; 2020 Apr; 10(4):627-636. PubMed ID: 32105410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of potential micro-messenger RNAs (miRNA-mRNA) interaction network of osteosarcoma.
    Xu K; Zhang P; Zhang J; Quan H; Wang J; Liang Y
    Bioengineered; 2021 Dec; 12(1):3275-3293. PubMed ID: 34252359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of significantly deregulated MicroRNAs in osteosarcoma based on bioinformatic analysis.
    Liu J; Wu S; Xie X; Wang Z; Lei Q
    Technol Health Care; 2021; 29(2):333-341. PubMed ID: 32568133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Key Genes and miRNAs in Osteosarcoma Patients with Chemoresistance by Bioinformatics Analysis.
    Xie B; Li Y; Zhao R; Xu Y; Wu Y; Wang J; Xia D; Han W; Chen D
    Biomed Res Int; 2018; 2018():4761064. PubMed ID: 29850522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a novel miRNA-target gene regulatory network in osteosarcoma by integrating transcriptome analysis.
    He C; Gao H; Fan X; Wang M; Liu W; Huang W; Yang Y
    Int J Clin Exp Pathol; 2015; 8(7):8348-57. PubMed ID: 26339404
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Li S; Wu X; Pei Y; Wang W; Zheng K; Qiu E; Zhang X
    DNA Cell Biol; 2019 Nov; 38(11):1323-1337. PubMed ID: 31536386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of aging/senescence-induced genes in osteosarcoma and predicting clinical prognosis.
    Lv Y; Wu L; Jian H; Zhang C; Lou Y; Kang Y; Hou M; Li Z; Li X; Sun B; Zhou H
    Front Immunol; 2022; 13():997765. PubMed ID: 36275664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Prognostic RBPs in Osteosarcoma.
    Li B; Fang L; Wang B; Yang Z; Zhao T
    Technol Cancer Res Treat; 2021; 20():15330338211004918. PubMed ID: 33754909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis.
    Li Y; Li L
    J Ovarian Res; 2019 Nov; 12(1):106. PubMed ID: 31703725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of key genes in osteosarcoma - before and after CDK7 treatment.
    An Y; Wang Y; Xu G; Liao Y; Huang G; Jin X; Xie C; Li Q; Yin D
    Medicine (Baltimore); 2021 Oct; 100(39):e27304. PubMed ID: 34596127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteosarcoma transcriptome data exploration reveals STC2 as a novel risk indicator in disease progression.
    Wang Z; Zeng Z; Gao F; Gui Z; Du J; Shen N; Shang Y; Yang Z; Shang L; Wei R; Ma W; Wang C
    BMC Med Genomics; 2023 Feb; 16(1):30. PubMed ID: 36803385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The genetic basis for inactivation of Wnt pathway in human osteosarcoma.
    Du X; Yang J; Yang D; Tian W; Zhu Z
    BMC Cancer; 2014 Jun; 14():450. PubMed ID: 24942472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting novel genes and pathways associated with osteosarcoma by using bioinformatics analysis.
    Dong B; Wang G; Yao J; Yuan P; Kang W; Zhi L; He X
    Gene; 2017 Sep; 628():32-37. PubMed ID: 28687333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating age‑induced differentially expressed genes and potential molecular mechanisms in osteosarcoma based on integrated bioinformatics analysis.
    Wang JS; Duan MY; Zhong YS; Li XD; Du SX; Xie P; Zheng GZ; Han JM
    Mol Med Rep; 2019 Apr; 19(4):2729-2739. PubMed ID: 30720085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioinformatic analysis of microRNA-mRNA expression profiles of bladder tissue induced by bladder outlet obstruction in a rat model.
    Duan LJ; Cao QF; Xu D; Liu HL; Qi J
    Mol Med Rep; 2017 Oct; 16(4):4803-4810. PubMed ID: 28791388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the molecular mechanisms of osteosarcoma by the integrated analysis of mRNAs and miRNA microarrays.
    Shen H; Wang W; Ni B; Zou Q; Lu H; Wang Z
    Int J Mol Med; 2018 Jul; 42(1):21-30. PubMed ID: 29620143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of microRNA-messenger networks for human osteosarcoma.
    Ma G; Zhang C; Luo W; Zhao JL; Wang X; Qian Y
    J Cell Physiol; 2019 Aug; 234(8):14145-14153. PubMed ID: 30666640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined analysis of DNA methylation and gene expression profiles of osteosarcoma identified several prognosis signatures.
    Tian W; Li Y; Zhang J; Li J; Gao J
    Gene; 2018 Apr; 650():7-14. PubMed ID: 29407229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An imprinted non-coding genomic cluster at 14q32 defines clinically relevant molecular subtypes in osteosarcoma across multiple independent datasets.
    Hill KE; Kelly AD; Kuijjer ML; Barry W; Rattani A; Garbutt CC; Kissick H; Janeway K; Perez-Atayde A; Goldsmith J; Gebhardt MC; Arredouani MS; Cote G; Hornicek F; Choy E; Duan Z; Quackenbush J; Haibe-Kains B; Spentzos D
    J Hematol Oncol; 2017 May; 10(1):107. PubMed ID: 28506242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.